Virology News and Research

Latest Virology News and Research

Year-round flu vaccinations for pregnant mothers benefit babies in subtropical regions

Vaccinating pregnant mothers year-round against flu in the resource-challenged region of subtropical Nepal reduced infant flu virus infection rates by an average of 30 percent, increased birth weights by 15 percent and resulted in babies having less influenza, according to a study published in The Lancet Infectious Diseases.

16 May 2017

Study reveals unique retinal scar in Ebola survivors

Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.

16 May 2017

New approach could help improve management decisions during Ebola outbreak

A new approach to information gathering could allow scientists to quickly identify the most effective way to manage a disease outbreak, an advance that could save lives.

16 May 2017

IBM scientists identify new way to trigger the body's immune response to fight diseases

IBM announced its researchers have identified a new way to trigger the body's immune response by using polymer-coated graphene sheets. The research was recently published in Nature Communications.

16 May 2017

Researchers develop simple urine-based test for rapid and accurate detection of Zika virus

There is no vaccine. No medication. And, no quick, reliable test for Zika virus … until now. Babies born with the virus often have lifelong, devastating birth defects.

15 May 2017

Study provides insights into how HCMV infection causes birth defects

Fresh insights into how a common virus replicates could pave the way for new therapies to stop its spread.

15 May 2017

Scientists discover simple way to use light for steering killer immune cells toward tumors

The science behind harnessing the immune system to fight cancer is complicated, but a University of Rochester Medical Center laboratory discovered a simple, practical way to use light and optics to steer killer immune cells toward tumors.

15 May 2017

Scientists uncover potential strategy to shock and kill HIV virus

Scientists at the Gladstone Institutes discovered that an enzyme called SMYD2 could be a new therapeutic target for flushing out the HIV that hides in infected individuals. Overcoming this latent virus remains the most significant obstacle to a cure.

15 May 2017

Immunoreceptor promotes tumor growth in mouse models of liver cancer driven by inflammation

Boosting a part of the immune system known to have anti-tumor properties may actually help tumors grow in cancers linked to chronic inflammation.

12 May 2017

Researchers uncover structural details that make eye-targeting virus a better tool for future therapies

In their quest to replicate themselves, viruses have gotten awfully good at tricking human cells into pumping out viral proteins. That's why scientists have been working to use viruses as forces for good: to deliver useful genes to human cells and help patients who lack important proteins or enzymes.

12 May 2017

Phase 1 trial shows safety and tolerability of oncolytic HSV-1 for children, young adults with cancer

HSV1716 – an oncolytic herpes simplex virus-1 – has been studied in adults via injection into the brain and superficial tumors.

11 May 2017

Research findings identify protein as potential new drug target for HCMV infections

Scientists have demonstrated that a human protein known as valosin containing protein (VCP) is essential for replication of human cytomegalovirus. The findings, published in PLOS Pathogens, identify VCP as a potential new treatment target.

11 May 2017

Study finds substantial increase in hepatitis C infections among pregnant women

Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.

11 May 2017

CUMC researchers create new organoids that mimic features of full-sized lung

New lung "organoids"-tiny 3-D structures that mimic features of a full-sized lung- have been created from human pluripotent stem cells by researchers at Columbia University Medical Center. The team used the organoids to generate models of human lung diseases in a lab dish, which could be used to advance our understanding of a variety of respiratory diseases.

11 May 2017

Introduction of ART has increased life expectancy in HIV patients by 10 years

A study published in the journal The Lancet HIV has found an increase in life expectancy of 20-year-old HIV patients in the EU and North America who had started antiretroviral therapy (ART) after it was introduced mid-1990s. When compared with patients who were not treated with ART, the life expectancy had increased by around a decade in these patients.

11 May 2017

Preclinical results of translational research show favorable outcomes in developing Zika virus vaccine

Preclinical results of research by City College of New York scientists and TechnoVax, Inc. in animal models demonstrate favorable outcomes in developing a vaccine against the mosquito-borne Zika virus.

11 May 2017

Sangamo Therapeutics and Pfizer team up for development of Hemophilia A gene therapy

Sangamo Therapeutics, Inc. and Pfizer Inc. today announced an exclusive, global collaboration and license agreement for the development and commercialization of gene therapy programs for Hemophilia A, including SB-525, one of Sangamo's four lead product candidates, which Sangamo expects will enter the clinic this quarter.

11 May 2017

Scientists develop easy-to-use diagnostic test that could rapidly detect flu

The threat of a major flu pandemic is a perennial concern. Now scientists have developed a fast and easy-to-use point-of-care diagnostic test that could one day help doctors and hospitals head off the rapid spread of the flu.

10 May 2017

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

St. Jude Children's Research Hospital and the Serum Institute of India have signed a licensing agreement to complete development and commercialization of a St. Jude vaccine against the respiratory syncytial virus (RSV), the virus that causes croup and lower respiratory infections. RSV kills about 160,000 people, primarily infants, worldwide each year.

10 May 2017

Transmission of mosquito-borne diseases may happen at lower temperatures than previously thought

Transmission of mosquito-borne diseases, such as Zika, occur at lower temperatures than previously thought, a recently released study co-authored by two University of South Florida researchers shows.

9 May 2017

Virology News and Research

Latest Virology News and Research

Year-round flu vaccinations for pregnant mothers benefit babies in subtropical regions

Study reveals unique retinal scar in Ebola survivors

New approach could help improve management decisions during Ebola outbreak

IBM scientists identify new way to trigger the body's immune response to fight diseases

Researchers develop simple urine-based test for rapid and accurate detection of Zika virus

Study provides insights into how HCMV infection causes birth defects

Scientists discover simple way to use light for steering killer immune cells toward tumors

Scientists uncover potential strategy to shock and kill HIV virus

Immunoreceptor promotes tumor growth in mouse models of liver cancer driven by inflammation

Researchers uncover structural details that make eye-targeting virus a better tool for future therapies

Phase 1 trial shows safety and tolerability of oncolytic HSV-1 for children, young adults with cancer

Research findings identify protein as potential new drug target for HCMV infections

Study finds substantial increase in hepatitis C infections among pregnant women

CUMC researchers create new organoids that mimic features of full-sized lung

Introduction of ART has increased life expectancy in HIV patients by 10 years

Preclinical results of translational research show favorable outcomes in developing Zika virus vaccine

Sangamo Therapeutics and Pfizer team up for development of Hemophilia A gene therapy

Scientists develop easy-to-use diagnostic test that could rapidly detect flu

Serum Institute signs licensing agreement to commercialize St. Jude vaccine against RSV

Transmission of mosquito-borne diseases may happen at lower temperatures than previously thought

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production